Facts You Need to Understand Perrigo Company Stock

By Harris Dyer • Thursday, January 19 09:40 • Permanent Link

Perrigo Company logged a -0.9% change during today's morning session, and is now trading at a price of $35.27 per share. The S&P 500 index moved -0.3%. PRGO's trading volume is 24,047 compared to the stock's average volume of 1,530,850.

Perrigo Company trades -26.14% away from its average analyst target price of $47.75 per share. The 4 analysts following the stock have set target prices ranging from $42 to $54, and on average have given Perrigo Company a rating of buy.

If you are considering an investment in PRGO, you'll want to know the following:

Perrigo Company has moved -10.4% over the last year, and the S&P 500 logged a change of -12.4%
Based on its trailing earnings per share of -0.82, Perrigo Company has a trailing 12 month Price to Earnings (P/E) ratio of -43.1 while the S&P 500 average is 15.97
PRGO has a forward P/E ratio of 12.7 based on its forward 12 month price to earnings (EPS) of $2.78 per share
The company has a price to earnings growth (PEG) ratio of 1.79 — a number near or below 1 signifying that Perrigo Company is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 1.0 compared to its sector average of 4.07
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed.
Based in Dublin, the company has 9,900 full time employees and a market cap of $4,748,752,896. Perrigo Company currently returns an annual dividend yield of 2.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.